Among the three specific siRNAs (siRNA#1, #2, and #3) targeting different sites of HOXB13‐AS1, the siRNA#3 was chosen for further research because of its stable interfering efficiency in both glioma cell lines. The gene discussed is HOXB13; the disease is central nervous system cancer.